Literature DB >> 15864519

[Recent studies concerning treatment of acute, ischemic infarcts].

I Q Grunwald1, T Struffert, U Dorenbeck, P Papanagiotou, W Reith.   

Abstract

This article gives an overview over past and present studies concerning the acute management of stroke. Stroke trials involving intra-arterial thrombolytic agents, either alone or in combination with other therapies, are described.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15864519     DOI： 10.1007/s00117-005-1219-9

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


  35 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

Authors:  A E Baird; A Benfield; G Schlaug; B Siewert; K O Lövblad; R R Edelman; S Warach
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

3.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

4.  Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  J M Gebel; C A Sila; M A Sloan; C B Granger; K W Mahaffey; J Weisenberger; C L Green; H D White; J M Gore; W D Weaver; R M Califf; E J Topol
Journal:  Stroke       Date:  1998-03       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Does arterial recanalization improve outcome in carotid territory stroke?

Authors:  R von Kummer; R Holle; L Rosin; M Forsting; W Hacke
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

7.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Authors:  J M Gore; M Sloan; T R Price; A M Randall; E Bovill; D Collen; S Forman; G L Knatterud; G Sopko; M L Terrin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

10.  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors: 
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321
View more
  1 in total

Review 1.  [Stroke].

Authors:  F J Ahlhelm; N Naumann; A Haass; I Grunwald; G Schulte-Altedorneburg; K Fassbender; W Reith
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.